Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02BZV
|
||||
Former ID |
DNC007745
|
||||
Drug Name |
BMS-1
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529859] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H30FN3O2
|
||||
Canonical SMILES |
CC1=NC(=C(N1CCCCCCNC(=O)OC2=CC=CC=C2F)C3=CC=CC=C3)C4=CC<br />=CC=C4
|
||||
InChI |
1S/C29H30FN3O2/c1-22-32-27(23-14-6-4-7-15-23)28(24-16-8-5-9-17-24)33(22)21-13-3-2-12-20-31-29(34)35-26-19-11-10-18-25(26)30/h4-11,14-19H,2-3,12-13,20-21H2,1H3,(H,31,34)
|
||||
InChIKey |
LHAHTHILLRCRBM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529859] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.